Clinical Bottom Line Clinical Scenario OTSC Efficacy Standard Deployment Protocol Acute Iatrogenic Perforation Highly effective (salvages surgical intervention). Suction tissue […]
Clinical Bottom Line Dietary Protocol Mechanism in IBD Primary Application Exclusive Enteral Nutrition (EEN) Bowel rest, modulation of microbiome, and
Clinical Bottom Line Stress Interaction Biological Mechanism Clinical Reality Etiology (Causation) No direct primary pathological causation. Stress does NOT cause
Clinical Bottom Line Surgical Intervention Specific Disease State Curative Potential IPAA (J-Pouch) Refractory Ulcerative Colitis. Curative for colonic disease, but
Clinical Bottom Line Distinguishing Feature Ulcerative Colitis (UC) Crohn’s Disease (CD) Anatomical Distribution Continuous from the rectum, limited to the
Clinical Bottom Line Diagnostic Tool Primary Utility Clinical Limitation Fecal Calprotectin Highly sensitive non-invasive screening for active mucosal inflammation. Non-specific;
Clinical Bottom Line IBD Complication Pathophysiology Therapeutic Approach Fibrotic Strictures (CD) Chronic transmural inflammation leading to collagen deposition and luminal
Clinical Bottom Line Pathogenic Vector Mechanism in IBD Therapeutic Target Genetic Susceptibility NOD2/CARD15 mutations impairing bacterial recognition. Currently non-targetable; prognostic
Clinical Bottom Line Condition Underlying Pathology Alarm Symptoms (Red Flags) Irritable Bowel Syndrome (IBS) Functional disorder of motility and visceral
Clinical Bottom Line Device System Clip Design Specific Advantages Ovesco OTSC Bear-trap hinge design (Nitinol). Exceptional compressive strength; dedicated twin-graspers
